JP2024532780A5 - - Google Patents
Info
- Publication number
- JP2024532780A5 JP2024532780A5 JP2024508498A JP2024508498A JP2024532780A5 JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5 JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024508498 A JP2024508498 A JP 2024508498A JP 2024532780 A5 JP2024532780 A5 JP 2024532780A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridine
- methylmorpholine
- cancer
- group
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232983P | 2021-08-13 | 2021-08-13 | |
| US63/232,983 | 2021-08-13 | ||
| US202263317500P | 2022-03-07 | 2022-03-07 | |
| US63/317,500 | 2022-03-07 | ||
| PCT/US2022/074925 WO2023019259A1 (en) | 2021-08-13 | 2022-08-12 | Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532780A JP2024532780A (ja) | 2024-09-10 |
| JP2024532780A5 true JP2024532780A5 (enExample) | 2025-08-18 |
Family
ID=83188606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508498A Pending JP2024532780A (ja) | 2021-08-13 | 2022-08-12 | Ｖｐｓ３４阻害剤を使用した併用療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250127790A1 (enExample) |
| EP (1) | EP4384180A1 (enExample) |
| JP (1) | JP2024532780A (enExample) |
| AU (1) | AU2022326573A1 (enExample) |
| CA (1) | CA3228766A1 (enExample) |
| TW (1) | TW202320797A (enExample) |
| WO (1) | WO2023019259A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2630970A (en) * | 2023-06-15 | 2024-12-18 | Duke Street Bio Ltd | PARP1 inhibitor compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015108881A1 (en) * | 2014-01-14 | 2015-07-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| ES2821400T3 (es) | 2016-02-19 | 2021-04-26 | Sprint Bioscience Ab | Compuestos de 6-heterociclil-4-morfolin-4-ilpiridin-2-ona útiles para el tratamiento del cáncer y la diabetes |
| JP7199737B2 (ja) * | 2017-08-23 | 2023-01-06 | スプリント バイオサイエンス アクティエボラーグ | ピリジルピリドン化合物 |
| TW202325302A (zh) * | 2017-08-23 | 2023-07-01 | 瑞典商斯普林特生物科技公司 | 吡啶胺-吡啶酮及嘧啶胺-吡啶酮化合物 |
| WO2020008046A1 (en) * | 2018-07-06 | 2020-01-09 | Sprint Bioscience Ab | Biomarker |
-
2022
- 2022-08-12 WO PCT/US2022/074925 patent/WO2023019259A1/en not_active Ceased
- 2022-08-12 EP EP22764625.4A patent/EP4384180A1/en active Pending
- 2022-08-12 JP JP2024508498A patent/JP2024532780A/ja active Pending
- 2022-08-12 TW TW111130481A patent/TW202320797A/zh unknown
- 2022-08-12 US US18/683,078 patent/US20250127790A1/en active Pending
- 2022-08-12 AU AU2022326573A patent/AU2022326573A1/en active Pending
- 2022-08-12 CA CA3228766A patent/CA3228766A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025143253A (ja) | Ｂｒｍ標的化化合物および関連使用方法 | |
| US7838524B2 (en) | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | |
| JP2021119196A5 (enExample) | ||
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| JP2022531801A5 (enExample) | ||
| TW200534853A (en) | Synergistic methods and compositions for treating cancer | |
| RU2018131766A (ru) | 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета | |
| KR102359759B1 (ko) | 세린/트레오닌 키나제 저해제 | |
| JP2017505794A5 (enExample) | ||
| JP2012525395A5 (enExample) | ||
| EA013231B1 (ru) | Замещенные амидные производные в качестве ингибиторов протеинкиназы | |
| MX2008006979A (es) | Compuestos de urea utiles en el tratamiento contra el cancer. | |
| JP2014500308A (ja) | Ｖｐｓ３４阻害剤としてのビヘテロアリール化合物 | |
| ZA200205988B (en) | 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors. | |
| JP2015205880A (ja) | Ｃ−ｆｍｓおよび／またはｃ−ｋｉｔ活性を調節する化合物およびその用途 | |
| EA029473B1 (ru) | Применение ингибиторов pi3k для лечения острой и церебральной малярии | |
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP7688042B2 (ja) | アミド化合物およびその使用 | |
| FI3672948T3 (fi) | Pyridiiniamiinipyridoni- ja pyrimidiiniamiinipyridoniyhdisteitä | |
| JP2019505595A5 (enExample) | ||
| US20210355104A1 (en) | Adenosine receptor binding compounds | |
| JP2018532778A5 (enExample) | ||
| JP2024532780A5 (enExample) | ||
| JP2020531486A5 (enExample) | ||
| JP2020531487A5 (enExample) |